Early results of the randomized, multicenter, controlled evaluation of S-1 and oxaliplatin as neoadjuvant chemotherapy for Chinese advanced gastric cancer patients (RESONANCE Trial)

被引：3
|
作者：
Wang, Xinxin
Li, Shuo
Xie, Tianyu
Lu, Yixun
Guo, Xin
Lin, Chen
机构：
[1] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
280
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Randomized, multicenter, controlled evaluation of S-1 and oxaliplatin (SOX regimen) as neoadjuvant chemotherapy for advanced gastric cancer patients (RESONANCE trial).
    Li, Tao
    Chen, Lin
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [2] The research progress in randomized, multicenter, controlled evaluation of S-1 and oxaliplatin as neoadjuvant chemotherapy for advanced gastric cancer patients
    Wang, X.
    Chen, L.
    ANNALS OF ONCOLOGY, 2017, 28
  • [3] The protocol of a prospective, multicenter, randomized, controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer: RESONANCE-II trial
    Xinxin Wang
    Shuo Li
    Yihong Sun
    Kai Li
    Xian Shen
    Yingwei Xue
    Pin Liang
    Guoli Li
    Luchuan Chen
    Qun Zhao
    Guoxin Li
    Weihua Fu
    Han Liang
    Hairong Xin
    Jian Suo
    Xuedong Fang
    Zhichao Zheng
    Zekuan Xu
    Huanqiu Chen
    Yanbing Zhou
    Yulong He
    Hua Huang
    Linghua Zhu
    Kun Yang
    Jiafu Ji
    Yingjiang Ye
    Zhongtao Zhang
    Fei Li
    Xin Wang
    Yantao Tian
    Sungsoo Park
    Lin Chen
    BMC Cancer, 21
  • [4] The protocol of a prospective, multicenter, randomized, controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer: RESONANCE-II trial
    Wang, Xinxin
    Li, Shuo
    Sun, Yihong
    Li, Kai
    Shen, Xian
    Xue, Yingwei
    Liang, Pin
    Li, Guoli
    Chen, Luchuan
    Zhao, Qun
    Li, Guoxin
    Fu, Weihua
    Liang, Han
    Xin, Hairong
    Suo, Jian
    Fang, Xuedong
    Zheng, Zhichao
    Xu, Zekuan
    Chen, Huanqiu
    Zhou, Yanbing
    He, Yulong
    Huang, Hua
    Zhu, Linghua
    Yang, Kun
    Ji, Jiafu
    Ye, Yingjiang
    Zhang, Zhongtao
    Li, Fei
    Wang, Xin
    Tian, Yantao
    Park, Sungsoo
    Chen, Lin
    BMC CANCER, 2021, 21 (01)
  • [5] S-1 Combined with Oxaliplatin as First Line Chemotherapy for Chinese Advanced Gastric Cancer Patients
    Liu, Bixia
    Ying, Jieer
    Luo, Cong
    Xu, Qi
    Zhu, Liming
    Zhong, Haijun
    HEPATO-GASTROENTEROLOGY, 2012, 59 (114) : 649 - 653
  • [6] Surgical outcomes in patients with locally advanced gastric cancer treated with S-1 and oxaliplatin as neoadjuvant chemotherapy
    Feng, Daofu
    Leong, Meiha
    Li, Ting
    Chen, Lin
    Li, Tao
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2015, 13
  • [7] Surgical outcomes in patients with locally advanced gastric cancer treated with S-1 and oxaliplatin as neoadjuvant chemotherapy
    Daofu Feng
    Meiha Leong
    Ting Li
    Lin Chen
    Tao Li
    World Journal of Surgical Oncology, 13
  • [8] Phase II trial of S-1 combined with oxaliplatin (SOX) as neoadjuvant chemotherapy for locally advanced gastric cancer
    Chen, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [9] Neoadjuvant Docetaxel, Oxaliplatin, and S-1 in Resectable Advanced Gastric Cancer
    Mo, Dun-Chang
    Qin, Lang
    Ye, Lin-Jing
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (34) : 3883 - +
  • [10] Neoadjuvant chemotherapy with S-1 and CDDP in advanced gastric cancer
    Kochi, Mitsugu
    Fujii, Masashi
    Kanamori, Noriaki
    Kaiga, Teruo
    Takahashi, Toru
    Kobayashi, Michiyo
    Takayama, Tadatoshi
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2006, 132 (12) : 781 - 785
12345